title: [Early and advanced rheumatoid arthritis. Diagnosis and state of the art therapy strategy].
abstract: The diagnosis of rheumatoid arthritis (RA) is often based on classification criteria. In 2010 ACR and EULAR presented new classification criteria for RA which allow patients with a high risk for persistent, chronic and erosive arthritis and therefore fulfill the current definition of RA, to be defined. Therapy of RA should be initiated as early as possible. Methotrexate remains the first-line therapy of RA. In patients showing insufficient response of RA, biological agents have been demonstrated to be an effective second-line therapy. It is essential to define and follow an individual treatment target to obtain remission or low disease activity. This target should be reassessed regularly and treatment should be correspondingly adapted to achieve the target.
authors.affiliation: Klinik für Rheumatologie und klinische Immunologie und Rheumatologikum, Schön Klinik Hamburg Eilbek, Dehnhaide 120, 22081, Hamburg, Deutschland. wollenhaupt@rheumatologikum.de
authors.forename: J
authors.initials: J
authors.lastname: Wollenhaupt
authors.forename: K
authors.initials: K
authors.lastname: Krüger
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000628:therapy*; D042241:Early Diagnosis; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008727:Methotrexate / Q000627:therapeutic use*; D055502:Secondary Prevention / Q000379:methods
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate